American chemical society - 238th national meeting & exposition. Novel small molecule therapeutics

Research output: Contribution to journalArticle

Abstract

The Novel Small Molecule Therapeutics session of the American Chemical Society 238th National Meeting and Exposition, held in Washington DC, included topics covering new therapeutic developments in CNS, anti-infective, cardiovascular and anti-inflammatory applications. This conference report highlights selected presentations on PAR2 (protease-activated receptor 2) antagonists, adenosine and P2Y receptor agonists and antagonists, antimicrobials and neuroprotective compounds.

Original languageEnglish
Pages (from-to)612-613
Number of pages2
JournalIDrugs
Volume12
Issue number10
StatePublished - 1 Oct 2009

Fingerprint

Purinergic P1 Receptor Agonists
PAR-2 Receptor
Purinergic P1 Receptor Antagonists
Anti-Inflammatory Agents
Therapeutics

Cite this

@article{400c25820e3e4120acdb73319b839bfb,
title = "American chemical society - 238th national meeting & exposition. Novel small molecule therapeutics",
abstract = "The Novel Small Molecule Therapeutics session of the American Chemical Society 238th National Meeting and Exposition, held in Washington DC, included topics covering new therapeutic developments in CNS, anti-infective, cardiovascular and anti-inflammatory applications. This conference report highlights selected presentations on PAR2 (protease-activated receptor 2) antagonists, adenosine and P2Y receptor agonists and antagonists, antimicrobials and neuroprotective compounds.",
author = "David Rotella",
year = "2009",
month = "10",
day = "1",
language = "English",
volume = "12",
pages = "612--613",
journal = "IDrugs",
issn = "1369-7056",
publisher = "Current Drugs Ltd.",
number = "10",

}

American chemical society - 238th national meeting & exposition. Novel small molecule therapeutics. / Rotella, David.

In: IDrugs, Vol. 12, No. 10, 01.10.2009, p. 612-613.

Research output: Contribution to journalArticle

TY - JOUR

T1 - American chemical society - 238th national meeting & exposition. Novel small molecule therapeutics

AU - Rotella, David

PY - 2009/10/1

Y1 - 2009/10/1

N2 - The Novel Small Molecule Therapeutics session of the American Chemical Society 238th National Meeting and Exposition, held in Washington DC, included topics covering new therapeutic developments in CNS, anti-infective, cardiovascular and anti-inflammatory applications. This conference report highlights selected presentations on PAR2 (protease-activated receptor 2) antagonists, adenosine and P2Y receptor agonists and antagonists, antimicrobials and neuroprotective compounds.

AB - The Novel Small Molecule Therapeutics session of the American Chemical Society 238th National Meeting and Exposition, held in Washington DC, included topics covering new therapeutic developments in CNS, anti-infective, cardiovascular and anti-inflammatory applications. This conference report highlights selected presentations on PAR2 (protease-activated receptor 2) antagonists, adenosine and P2Y receptor agonists and antagonists, antimicrobials and neuroprotective compounds.

UR - http://www.scopus.com/inward/record.url?scp=70349777673&partnerID=8YFLogxK

M3 - Article

C2 - 19790006

AN - SCOPUS:70349777673

VL - 12

SP - 612

EP - 613

JO - IDrugs

JF - IDrugs

SN - 1369-7056

IS - 10

ER -